-defensins are cyclic octadecapeptides encoded by the modified ␣-defensin genes of certain nonhuman primates. The recent demonstration that human ␣-defensins could prevent deleterious effects of anthrax lethal toxin in vitro and in vivo led us to examine the effects of -defensins on Bacillus anthracis (Sterne). We tested rhesus -defensins 1-3, retrocyclins 1-3, and several analogues of RC-1. Low concentrations of -defensins not only killed vegetative cells of B. anthracis (Sterne) and rendered their germinating spores nonviable, they also inactivated the enzymatic activity of anthrax lethal factor and protected murine RAW-264.7 cells from lethal toxin, a mixture of lethal factor and protective antigen. Structure-function studies indicated that the cyclic backbone, intramolecular tri-disulfide ladder, and arginine residues of -defensins contributed substantially to these protective effects. Surface plasmon resonance studies showed that retrocyclins bound the lethal factor rapidly and with high affinity. Retrocyclin-mediated inhibition of the enzymatic activity of lethal factor increased substantially if the enzyme and peptide were preincubated before substrate was added. The temporal discrepancy between the rapidity of binding and the slowly progressive extent of lethal factor inhibition suggest that post-binding events, perhaps in situ oligomerization, contribute to the antitoxic properties of retrocyclins. Overall, these findings suggest that -defensins provide molecular templates that could be used to create novel agents effective against B. anthracis and its toxins.
macaques (28 -30) , whose three -defensins are named rhesus -defensins (RTDs) 1-3. Humans have multiple -defensin genes, including some that are transcribed. However, human genes and their transcripts contain a premature stop codon that aborts successful translation (27, 31) . Retrocyclins 1-3 are synthetic -defensin peptides, whose structures are based on human multiple -defensin pseudogenes. Conceptually, they represent peptides last produced by apes whose eventual progeny included gorillas, chimps, and humans. The purpose of this study was to examine the effects of -defensins on vegetative cells and spores of B. anthracis and on the enzymatic and cytotoxic properties of anthrax LF.
EXPERIMENTAL PROCEDURES

Retrocyclin and Other Peptides
Retrocyclins (31) and HNP-1, -2, and -3 (32) were prepared by solid-phase peptide synthesis as described previously. Peptide concentrations were established by quantitative amino acid analysis (for -defensins) or by A 280 measurement (for HNPs). Table 1 contains the sequence of every peptide used in this study.
Spore Preparation
B. anthracis (Sterne strain 7702) spores were prepared as described elsewhere (33) . Briefly, B. anthracis was grown in Trypticase soy broth medium (T8907, Sigma) at 30°C with constant shaking at 250 rpm for 5-7 days until sporulation. The culture was centrifuged at 6000 ϫ g for 20 min at 4°C. The pellet was resuspended in sterile water, and cultured at 30°C for two more days with constant shaking to promote further sporulation and bacterial lysis. Complete spore formation was confirmed by light microscopy. Spores were centrifuged at 6000 ϫ g for 20 min at 4°C and washed five times with sterile water. Before use, the spores were heated at 65°C for 30 min to kill any germinated or germinating spores. No intact bacilli were present at this stage. Serial dilutions of the spore preparation were plated on Trypticase soy agar plates to determine the concentration of colony forming units.
Radial Diffusion Assay
Two-stage radial diffusion assays were used to test the antimicrobial activity of peptides against B. anthracis spores and vegetative cells (34) .
Stage 1-1-4 ϫ 10 6 colony forming units were dispersed in a thin 1% agarose underlay gel containing 10 mM phosphate buffer (pH 7.4), 100 mM NaCl, and 1% (v/v) Trypticase soy broth. A 6 ϫ 6 array of wells, each with a 3-mm diameter and 9-l capacity, was punched. Serially diluted peptide solutions containing 250, 79, 25, 7.9, 2.5, and 0.79 g/ml peptides (8 l each) were added to each set of 6 wells. The plate was incubated at 37°C for 3 h to allow the peptides to diffuse into the underlay gel.
Stage 2-An overlay gel containing 60 mg/ml Trypticase soy broth powdered medium plus 1% agarose was poured over the underlay gel, and the plate was incubated overnight to allow surviving bacteria to form micro-colonies. The clear zones around each well were measured 18 -24 h later. To determine the minimal effective concentration (MEC), a linear regression function relating the adjusted diameter (zone diameter minus the well diameter) to the log 10 peptide concentration was calculated. The X-intercept defined by this function gives the MEC. Typically, the correlation coefficient (r 2 ) was Ͼ0.98.
Enzymatic Assay
The enzymatic activity of anthrax lethal factor (LF), a zinc metalloprotease, was measured by monitoring cleavage of a specific substrate by fluorescence resonance energy transfer. The substrate, purchased from Calbiochem, was an internally quenched, N-acetylated, C-7-amino-4-methylcoumarin derivative of a 14-mer mitogen-activated protein kinase/extracellular signal-regulated-kinase-2 (MEK-2) peptide. Its cleavage by recombinant LF (Calbiochem) resulted in increased fluorescence that was monitored kinetically with an fmax fluorescence microplate reader (Molecular Devices, Sunnyvale, CA), with excitation set at 360 nm and emission at 460 nm. Unless otherwise noted, 100 nM LF was incubated for 30 min at room temperature with the specified amount of -defensin peptide before 50 M substrate (final concentration) was added.
Murine Macrophage Intoxication
Murine macrophage-like RAW 264.7 cells were seeded in 384-well plates at 4000 cells per well and incubated overnight at 37°C. The medium was replaced by 20 l of fresh Dulbecco's modified Eagle's medium containing 25 mM HEPES, 2 mM glutamine, 100 g (each) penicillin and streptomycin, and 1% fetal bovine serum. The ␣-and -defensin peptides were serially diluted into the same medium, and 20 l was added to appropriate wells. Peptide concentrations 
Ultracentrifugation
Sedimentation equilibrium runs were performed at 25°C in 12-mm path length double sector cells on a Beckman Optima XL-A analytical ultracentrifuge. Absorption was monitored at 228 nm for 0.1 mg/ml samples and 260 nm for 1.0 mg/ml samples. Peptide samples were in 100 mM NaCl, 10 mM Tris, pH 7.4, and sedimentation equilibrium profiles were measured at 40,000 and 50,000 rpm. The data were initially fitted with a nonlinear least-squares exponential fit for a single ideal species using the Beckman Origin-based software (version 3.01). Preliminary analysis of the association behavior used the global analysis software (the "multifit" option of the abovementioned software) to analyze four scans simultaneously, corresponding to protein at 0.1 mg/ml at 40,000 and 50,000 rpm and protein at 1.0 mg/ml at 40,000 and 50,000 rpm. The partial specific volume (0.711 of RC-1 was calculated from its amino acid composition (35) .
Surface Plasmon Resonance Studies
SPR experiments were performed on a BIAcore 3000 system (BIAcore AB, Uppsala, Sweden). Proteins were immobilized on a BIAcore CM5 sensor chip using the BIAcore amine-coupling protocol. Analytes were introduced into the flow cells in a running buffer containing 10 mM HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA. The running buffer also contained 0.005% polysorbate-20 to reduce nonspecific binding. Values were corrected for background binding to the CM5 chip. Data were analyzed with BIAevaluation 3.1 software, and curve fitting was done with an assumption of 1:1 binding.
SPR results are expressed in resonance units (RUs). To calibrate the instrument, we synthesized [ 14 C]RC-2, which contained [
14 C]glycine (Sigma) and purchased 125 I-bovine serum albumin (BSA) from MP Biomedicals (Irvine, CA). The [ 14 C]RC-2 had a specific activity of 21.6 Ci/mg, and the 125 I-BSA had a specific activity of 987 Ci/mg. To calibrate the system for BSA, we immobilized a mouse anti-BSA monoclonal antibody (U.S. Biological, Swampscott, MA) on a CM5 biosensor chip. After measuring the binding of 125 I-BSA (1 g/ml) to the biosensor chip, the bound analyte was recovered using the BIAcore Analyte Recovery Wizard program, and its radioactivity was measured in a Beckman liquid scintillation spectrometer. From seven such measurements, we determined that 1 RU of BSA was equivalent to 13.35 Ϯ 0.55 pg (mean Ϯ S.E.). We used this value to estimate the amount of immobilized LF on the biosensor chip in experiments with retrocyclins. To obtain a conversion factor for RC-2, we used a biosensor that contained immobilized recombinant gp120 (BioDesign International, Saco, ME). From these experiments, we determined that 1 RU corresponded to 4.41 Ϯ 0.15 pg of RC-2 (mean Ϯ S.E., n ϭ 3). We used these values to estimate the stoichiometry with which retrocyclins bound to LF.
Computational Methods
Docking was accomplished with the AutoDock 3.06 suite of programs (36) which assumes that the macromolecule is rigid, while the ligand is allowed torsional flexibility. A Lamarckian genetic algorithm (LGA) searches the conformational space of the ligand in the vicinity of the macromolecule and ranks the docked molecules on the basis of its binding energy. Also available are two local search methods based on the method of Solis and Wets (37) and an empirical free energy function that estimates the binding free energy (36) . In the present work all protein and ligand hydrogen atoms were explicitly modeled, with polar and nonpolar atoms being assigned Lennard-Jones 12-10 and 12-6 parameters, respectively. They were added to the native and ligand complexed forms of anthrax lethal factor (Protein Data Bank designations 1J7N (38) , 1PWW (39) , and 1YQY) (40) and the ligand (L2) of 1PWW using the WHAT IF web interface (41) .
The NMR structures of RTD-1 and retrocyclin (RC)-2 (1HVZ and 2ATG) already had hydrogen atoms. RC-1 was generated by mutating RC-2 in silico with Pymol. 4 All water molecules were removed during docking. Partial charges were assigned to the protein atoms using all-atom charges of the AMBER force field (43) . Atomic solvation parameters and atomic fragmental volumes were added with the AddSol program of AutoDock 3.06. The Lennard-Jones parameters used for Zn 2ϩ , taken form the work of Stote and Karplus (44), successfully reproduced the crystal structures of L1 and L2 (Table  4) . Hydrogen atoms for the hydroxamate ligand of 1YQY (L1) were added with BABEL, 5 and partial charges were generated with GAMESS (46) . Ligand rotatable bonds for all docked ligands were defined using the AutoTors module of AutoDock.
Van der Waals and electrostatic energy grid maps were prepared using AutoGrid (36) . These grid maps define the cubic space in the vicinity of receptor in which the search for the optimally binding ligand conformer is focused. The grid points were spaced 0.375 Å apart and based on the centers of L1 and L2, with the grid sized to allow a 5-Å clearance on either side of the ligands in the x, y, and z dimensions. For RC-2 and RTD-1 two grid sizes were used. The first grid was based on the N terminus MAPPK-2 peptide in complex with anthrax lethal factor (1JKY) (38) , which spans the entire active site. This grid was therefore centered on the MAPKK-2 peptide, also with a 5-Å clearance on either side in the x, y, and z dimensions and a grid spacing of 0.375 Å. Later, when it was found that the RTD-1 and RC-2 docked only in a cavity close to the C-terminal end of the MAPKK-2 peptide in active site, the grid size was reduced to cover only that volume of space to improve the search efficiency. RC-1 was therefore docked using the smaller grid alone. The force-field parameters of AutoDock 2.4 were used to evaluate nonbonded interaction energies instead of using the parameters of AutoDock 3.0, which estimates free energies. This was because the presence of a large number of conforma-tional degrees of freedom in the docked ligands presented challenges with the estimation of the torsional free energy term (36) . The reported binding energies are therefore representative of binding enthalpies and not binding free energies. Electrostatic interactions were evaluated using a distance-dependent dielectric constant to model solvent effects.
For the global search using the LGA, the size of the initial random population was 200 individuals for the large grids and 50 individuals otherwise, the maximal number of energy evaluations was 2 ϫ 10 7 , the maximal number of generations was 500, the number of top individuals that survived into the next generation, the elitism, was 1, the probability that a gene would undergo a random change was 0.02, the crossover probability was 0.80, and the average of the worst energy was calculated over a window of ten generations.
For a pure local search, the pseudo-Solis and Wets method was used, whereas the Solis and Wets method was used for the LGA part of the local search. The parameters used for local search in both cases were a maximum of 1000 iterations per local search, the probability of performing a local search on an individual was 1.0, the maximal number of consecutive successes or failures before doubling or halving the step size of the local search was 4, and the lower bound on the step size, 0.01, was the termination criteria for the local search. For RTD-1 and RC-2, a total of 50 dockings was performed using the large grid before switching to the smaller grid. For the root-mean squared deviation (r.m.s.d.) calculation of docked of L1 and L2, their crystal coordinates were used as reference.
RESULTS
Activity against Spores and Bacilli-We used the capsuledeficient Sterne strain of B. anthracis to examine the antimicrobial activity of retrocyclins. Radial diffusion and colony counting assays were performed in the presence of physiological NaCl concentrations. Table 2 summarizes the results of our radial diffusion assays, which showed that RC-1 and HNP-1 killed vegetative B. anthracis cells with an MEC Ͻ 1 g/ml. Retrocyclin-1 also manifested this exceptional potency against B. anthracis spores, but HNP-1 did not (MEC 24.9 Ϯ 0.49 g/ml). Because RC-112, an all D-amino acid version of RC-1, and RC-110, a retroenantio version of RC-1 were as effective as the regular peptide, chiral interactions were apparently not required for antimicrobial activity. RC-111, the retro analog of RC-1, showed reduced activity against vegetative cells (MEC 13.6 Ϯ 2.78 g/ml) but had excellent activity against spores (MEC 0.32 Ϯ 0.04 g/ml). Table 2 also contains structure-function data. -Defensins possess a cyclic peptide backbone and three intramolecular disulfide bonds. RC-100ox, the immediate synthetic precursor of RC-1, contains the three disulfide bonds but has free amino and C termini. This peptide was ϳ3-fold less potent than cyclic RC-1 against vegetative B. anthracis bacteria, and ϳ36-fold less effective against B. anthracis spores. RC-100 IAA was derived from RC-1 by reducing its disulfide bonds with dithiothreitol and alkylating the liberated cysteine residues with iodoacetamide. RC-100 IAA thereby retained the net charge (ϩ4) and cyclic peptide backbone of RC-1 but lacked its internal tri-disulfide scaffold. RC100 IAA lacked activity (MEC Ͼ 250 g/ml) against vegetative cells and spores of B. anthracis (Sterne). Thus, both the cyclic backbone and the tri-disulfide ladder contributed to activity against B. anthracis.
In addition to its six cysteine residues, Retrocyclin-1 contains four residues each of arginine, isoleucine, and glycine. To assess the contribution of the arginines to its activity against B. anthracis (Sterne), we synthesized analogs in which 1, 2, 3, or 4 of these arginines were replaced by a glycine and/or a histidine residue. Replacing one (RC-107G) or both (RC-107GG) argi- nine residues in the ␤-turn region(s) of RC-1 had relatively little effect on activity against vegetative cells or spores (Table 2) . However, replacing all four arginines (RC-107G2H2) abolished activity (MEC Ͼ 250 g/ml). When we replaced three arginines (RC-107G2Ha and RC-107G2Hb), this abolished activity against B. anthracis spores (MEC Ͼ 250 g/ml), but activity against vegetative cells persisted (MEC 7.91 Ϯ 1.02 and 24.8 Ϯ 0.17 g/ml). Analogs of RC-2 containing a lysine instead of an arginine at position 4, 9, 10, 13, or 18 of RC-2 killed vegetative B. anthracis cells with an MEC Ͻ 1 g/ml, as did an analog in which both Arg-9 and Arg-10 were replaced by lysines (data not shown).
We also examined activity against vegetative cells of B. anthracis (Sterne) in colony count assays. Fig. 1 shows that mid-logarithmic and stationary phase organisms showed similar susceptibility to RC-2 and that its bactericidal activity was time-and concentration-dependent. In contrast, when we used colony count assays to test activity against B. anthracis (Sterne) spores, we saw no decrease in colony forming units/ml after 3 h of incubation with 25 g/ml RC-2 (data not shown). This suggests that the potent activity of RC-2 against B. anthracis spores seen in our radial diffusion assays (Table 2 ) was exerted after the spores had commenced to germinate, rather than against quiescent spores.
Effect on Enzymatic Activity-Anthrax LF is a highly substrate-specific Zn 2ϩ -metalloprotease. Table 3 summarizes the ability of 16 different -defensins to inhibit the enzymatic activity of LF. The tested peptides included RC-1 (RC-100) and its retro (RC-111), enantio (RC-112), and retroenantio (RC-110) analogs. Although these peptides were similar in composition, net charge, and sequence, the retro (RC-111) and enantio (RC-112) analogs were only half as potent as RC-1, and the retroenantio analog (RC-110) was ϳ25% as effective. Thus, chirality and polarity relative to the peptide backbone also contributed to the ability to inactivate LF. The cyclic backbone was extremely important, because the IC 50 of RC-100ox (the ␤-hairpin, noncyclic synthetic precursor of RC100) was increased 5-fold relative to RC-1.
Replacing one ␤-turn arginine reside with glycine (RC-107G) had slight effect on potency, but replacing two of them (RC-107GG) reduced potency 2-fold. Further replacement of a single ␤-sheet arginine with histidine (RC-107G2Ha and RC-107G2Hb) caused little further impairment, but replacing both of these arginines with histidines (RC-107G2H2), abolished it completely. These findings suggest that the arginines may operate in a pairwise fashion with respect to inhibiting the enzymatic activity of LF. Placing a lysine instead of an arginine at position 4, 9, 10, 13, or 18 of RC-2 neither enhanced nor diminished inhibitory activity against LF (data not shown).
Retrocyclins 1-3 and RTDs 1-3 had fairly similar potency (Table 3) . Although RC-2 appeared somewhat more effective than RC-1, the difference was relatively small, and not statistically significant. Retrocyclin-3 was less effective than RC-1 (p Ͻ 0.05), despite having two additional arginine residues that gave it a net charge of ϩ6 instead of ϩ4. The generally similar activity of the retrocyclins 1-3 and RTD 1-3 suggests that their ability to inhibit LF likely resides in features they all share, namely a cyclic backbone, a conserved tri-disulfide ladder, and certain arginine residues.
Effect of Preincubation- Fig. 2a shows that by preincubating LF with retrocyclin, inhibition of the enzymatic activity of the toxin was considerably enhanced. In the absence of preincubation, 2.5 M RC-1 inhibited enzymatic activity by ϳ20%. Inhibition increased to 40% after a 5-min preincubation, to 60% after 15-min preincubation, and to 80% after a 30-min preincubation. In Table 3 , inhibition was measured after a 30-min preincubation between recombinant LF and the indicated -defensin. Fig. 2b shows that increasing the substrate concentration did not reverse the inhibition of LF by RC-2, clearly indicating that the process was not competitive. The V max of RC-treated LF was considerably reduced, consistent with noncompetitive inhibition, and the K m was also reduced, from ϳ10 M to ϳ5 M, consistent with uncompetitive inhibition. Kinetics of Binding-We used SPR to examine the binding of RC-1 to immobilized anthrax LF (Fig. 3) . Binding isotherms are shown for two concentrations of RC-1: 4 g/ml (ϳ2 M) and 1 g/ml (ϳ0.5 M). Binding was rapid, with maximal binding reached after ϳ5 min. From these isotherms and others obtained at lower retrocyclin concentrations, the following constants were calculated for the binding of RC-1 to LF: k on , 1.99 ϫ 10 4 ; k off 1.51 ϫ 10 Ϫ3 ; K d , 79.1 nM. SPR experiments provide a readout in resonance units. To convert RUs to mass-based quantities, we performed experiments with [ 14 C]RC-2 and 125 I-BSA. From the former, we determined that 1 RU of RC-2 corresponded to 4.42 Ϯ 0.25 pg (mean Ϯ S.E., n ϭ 3). For 125 I-BSA, we determined that 1 RU was equivalent to 13.35 Ϯ 0.55 pg of protein (mean Ϯ S.E., n ϭ 7). If we apply the same RU/pg conversion factors to RC-1 and LF, respectively, the following estimates result. The 4422 RUs of LF affixed to the biosensor chip represents ϳ59.0 ng (or 0.66 pmol) of this toxin. When the biosensor was exposed to 4 g/ml RC-1, ϳ4000 RU of the defensin was bound (Fig. 3) . This corresponds to 17.7 ng or ϳ9.23 pmol of retrocyclin. Thus, each LF molecule bound ϳ14 molecules of retrocyclin. At 1 g/ml, when ϳ1500 RU of retrocyclin was bound, the molar ratio was 5.25 retrocyclins/LF.
The different kinetics of binding (rapid) and protease inhibition (slowly progressive) suggest that one or more post-binding steps may be responsible for the time-dependent nature of the inhibition of the enzymatic activity of LF shown in Fig. 2a . One post-binding event that could contribute to the progressive enzymatic inactivation is illustrated in Fig. 4 , which shows that RC-1 can oligomerize to form dimers or trimers. SDS-PAGE analysis also demonstrated this property (data not shown).
Prevention of Cellular Intoxication-The ability of ␣-and -defensins to protect RAW 264.7 cells from intoxication by LeTx, a mixture of PA and LF, is illustrated in Fig. 5. Fig. 5a confirms the protective activity of HNP-1 , which had an IC 50 of ϳ5.5 g/ml in this experiment. We obtained similar results in a second experiment (data not shown). Fig. 5b shows that RC-1 and -2 were also protective, acting with an IC 50 between 5.5 and 7.0 g/ml. Fig. 5c shows that RC-112, composed exclusively of D-amino acids, was about half as potent as RC-1, its enantiomer, acting with an IC 50 of ϳ15 g/ml. This panel also shows that RC110, the retroenantio analog of RC-1, had very little protective activity even though its net charge and composition mirrored that of RC-1. The results shown in Fig. 5 (b and c) (40) . The docking results are summarized in Table 4 with the final docked energy listed for the best docked ligands. In AutoDock, the docked energy is the sum of nonbonded ligand-receptor intermolecular energy and the nonbonded internal energy of the ligand (Table 4 ). L1 and L2 were docked as controls, and successfully reproduce the crystal structures in local searches with energies of Ϫ118. Because AutoDock assumes that the receptor is rigid and torsional flexibility is allowed in the ligand, the degree of flexibility of the ligand determines the computational complexity of the problem. Typical ligands docked with AutoDock usually have less than ten torsional degrees of freedom, whereas L2, even though just a small peptide, has 58 torsional degrees of freedom. Our goal in this modeling work was to dock RTD-1, RC-1, and RC-2, which are octadecapeptides with 44, 51, and 51 torsional degrees of freedom, respectively (after excluding backbone torsional degrees of freedom, because AutoDock cannot model torsional changes in loops). The computational complexity is therefore similar to the computational complexity of L2. However, despite the difficulties in docking outlined with L2, we believe that docking circular peptides with AutoDock may still be feasible, because torsional changes in linear peptides such as L2 would sample much greater conformational space than only side chain perturbations, as would largely be the case with the RTDs and the RCs. Also, to reduce the search space, we focused docking primarily on the activesite cavity, even though the stoichiometry of LF/RC-1 binding as determined by SPR indicates that RC-1 binds to multiple sites on the surface of LF. Our goal was, therefore, to search for RC or RTD binding that would directly interfere with the substrate binding.
Several patterns emerge from our results. When docked in the larger grid (see "Computational Methods"), all RC-2s and RTD-1s docked toward the C-terminal end of MAPKK-2 peptide in the active-site cavity (Fig. 6 ). It appears that the active site is too narrow toward the N-terminal side to make entry possible from that direction. Access to the active site is, therefore, most likely from the C-terminal side, and for later searches, the grid size was reduced to cover only the C-terminal cavity to make search more efficient. RC-1 and -2 and RTD-1 dock with energies of Ϫ303.03, Ϫ303.78, and Ϫ341.90 kcal/mol, respectively, which are significantly lower than that of the L2 peptide fragment with the local search, thus implying strong binding may be occurring in In the AutoDock output, the nonbonded interaction of each ligand atom with the receptor is listed. It is therefore possible to determine the contribution of each ligand residue to the intermolecular interaction energy. In the best docks for RTD-1, RC-1, and RC-2 60%, 60, and 62% of the total interaction energy is contributed by the arginines. This is not necessarily surprising because arginines hydrogen bond, besides interacting through electrostatic interactions, and hydrogen bonding energies an order of magnitude larger than van der Waals interactions. In particular, because we have the RC-107 series of mutants available, it is instructive to see the energetic contribution of each of the arginines in RC-1. The energetic contributions in kilocalories/mol of the four arginines are as follows: Ϫ22.59/R4, Ϫ0.22/R9, Ϫ56.75/ R13, and Ϫ9.83/R18. Keeping in mind the inherent symmetry of RC-1 structure, these energies correlate well with the observed inhibition of RC-1, RC-107G, and RC-107GG toward LF. For example, R 9 G hardly affects the IC 50 , but R 9,18 G almost doubles it (Table 3) .
The stoichiometry of RC-1 binding suggests that the binding is far from specific and that there are several binding sites on the enzyme surface. Docked RTD-1, RC-1, and RC-2, each of which probably represent one of several possible binding modes, show significant overlap with the N-terminal MAPPK-2 peptide binding site (Fig. 6 ) implying that they all compete for the same binding site, which contradicts the noncompetitive binding curves observed (Fig. 2b) . However, the k off indicates that the half-life of the binding is ϳ7.6 min (0.69302/k off ), implying the RC-1 binding can be practically considered irreversible compared with substrate binding, if the latter is assumed to be diffusionlimited. Such irreversible binding within the active site should also give noncompetitive binding curves of the sort observed (Fig. 2b) , because the irreversibly bound inhibitor would reduce the effective concentration of the active enzyme. Also, because the RCs self-aggregate, the slow onset of inhibition observed (Fig. 2a) can be explained as follows: once the enzyme surface is covered with RCs, these bound RCs may form nucleation sites for aggregation and compete with the binding to the active site itself, thus resulting in the slow onset of inhibition.
DISCUSSION
In nonhuman primates, such as rhesus macaques, -defensins are encoded by genes that encode a C-terminal "defensin" domain containing 12 residues, including 3 cysteines. Rhesus leukocytes trim and splice two such precursors into a cyclic, 18-residue, -defensin peptide. The human -defensin genes contain a premature stop codon, and humans lack -defensin peptides. Although the sequences of retrocyclins 1, 2, and 3 are based on human genome sequences, these peptides and their analogs were prepared by solid-phase chemical synthesis for this study.
Surprisingly few studies of -defensin peptides have appeared since their initial description by Selsted et al. in 1999 (29) , despite their novel characteristics and potential usefulness. Whereas many cyclic peptides are produced by plants, bacteria, or fungi, -defensins are the only known cyclic peptides of animal origin (47) (48) (49) . The ability of -defensins to bind carbohydrates (50) also makes them the smallest known lectins. Their broad antiviral spectrum encompasses human immunodeficiency virus type 1, influenza A, and herpes simplex viruses (31, 51, 52) , and its mechanisms have been the focus of many of our recent studies.
-Defensins were reported to kill some bacteria, but not others (29, 30, 53, 54) . The present studies show that B. anthracis is highly susceptible to their antibiotic effects. Our studies were stimulated by a recent report of Kim et al. (26) , showing that HNP-, a human ␣-defensin, inhibited the enzymatic activity of anthrax LF in a noncompetitive manner. We confirmed this observation for HNP-1 and extended it by showing that -defensins also inhibit LF in a noncompetitive manner (Fig. 2) . Both -defensins (Table 2) and HNP-1 (26) required intact disulfide bonds for this activity. On a molar basis, HNP-1 (3.4 kDa) and retrocyclins 1 and 2 (ϳ2 kDa) have similar molar potencies against LF, although retrocyclins are more active on a weight basis (Table 3) .
HNP-1 and RC-2 were equally active against B anthracis (Sterne) bacilli (Table 2 ). In killing B. anthracis bacilli (Fig. 1) and inactivating the enzymatic activity of LF (Fig. 2) , -defensins manifested a lag. With respect to the former, we speculated that this delay may have resulted from a requirement for oligomer formation in or near the active site of LF. Oligomerization could also contribute to the delayed onset of killing.
Many, but not all, antimicrobial peptides target the bacterial membrane by binding to it, altering its permeability and dissipating its trans-membrane electrochemical gradient. A relatively thick peptidoglycan wall, the murein sacculus, surrounds the membrane of a Gram-positive bacillus and protects it from destructive osmotic surges. Using fluorescein-labeled dextrans, Demchick and Koch (55) found that the murein sacculi of Escherichia coli and B. subtilis contain myriads of pores ("tesserae"), each formed by two octasaccharide chains that were crosslinked by two octapeptides. The effective diameter of the pores was ϳ41 Å, sufficiently large to allow the free passage of a 25-kDa globular hydrophilic molecule. Consequently, the thick peptidoglycan wall surrounding B. anthracis is unlikely to impede the transmural journey of -defensins to destinations in the bacterial membrane or beyond.
In radial diffusion experiments, HNP-1 and -defensins were active against B. anthracis spores, but the -defensins were far more potent that HNP-1 ( Table 2 ). The reason(s) for this difference remain to be elucidated. Because RC-1 and its all-Damino acid enantiomer, RC-112 had very similar MECs against B. anthracis cells and spores in radial diffusion assays (Table 2) , chiral interactions between -defensins and this organism are unlikely to contribute significantly to the bactericidal mechanism. This contrasts with the inhibition of LF (Table 3) . Here, RC-112 was significantly (p Ͻ 0.05) less effective than RC-1, suggesting that chiral interactions or relatively subtle structural factors have significant effects on the ability to inhibit this toxic metalloprotease.
Mayer-Scholl et al. (56) found than human neutrophils phagocytize (ingest) B. anthracis bacilli and spores and kill them via an oxygen-independent mechanism that uses ␣-defensins as its effectors. Neutrophils sequester ingested bacteria and spores in small membrane-bounded cytoplasmic vacuoles ("phagosomes") and deliver the contents of their defensin-containing "azurophil" storage granules to these phagosomes, achieving local defensin concentrations hundreds of times greater than the MEC of 24.9 g/ml shown in Table 2 (57, 58) .
Biophysical techniques, including oriented CD, x-ray diffraction, and solid-state NMR, have provided valuable insights into the effects of PG-1 and -defensins on membranes (42, 59 -64) . Solid-state NMR studies with uniaxially oriented phosphatidylcholine bilayers revealed that RTD-1 bound to the surface of such bilayers without perturbing its hydrophobic core (64) . In contrast, when RTD-1 bound bilayers containing phosphatidylcholine and phosphatidylglycerol lipids, it induced much greater orientational disorder, consistent with its selectivity for anionic bacterial membranes versus cholesterol-rich zwitterionic mammalian membranes. RTD-1 induced curvature stress and micrometer-diameter lipid cylinders in anionic membranes. In all of these structural and dynamic features, the behavior of membrane-associated RTD-1 differed significantly from that of PG-1 (64) . Protegrin PG-1, a noncyclic ␤-sheet peptide octadecapeptide found in porcine neutrophils (45) , was also highly effective against B. anthracis spores. However, PG-1 manifests appreciable cytotoxicity, and the peptide is hemolytic for human erythrocytes. In marked contrast, -defensins such as RC-2 are nonhemolytic and noncytotoxic, even when tested at high concentrations (52) .
A dangerous and very often lethal form of human anthrax occurs following the inhalation of aerosolized B. anthracis spores. We have shown that certain -defensins not only exert potent antibiotic activity against the spores and bacilli of B. anthracis, they can also inactivate LF and protect cells from destruction by anthrax lethal toxin (LF plus PA). These findings suggest that -defensins provide molecular templates that could be used to create novel agents effective against B. anthracis and its toxins. Kim et al. (26) reported that BALB/c mice treated intravenously with 500 g of mixture of human ␣-defensins (HNPs) 1-3 survived a dose of anthrax LeTx that killed untreated mice by Day 2. That an intravenous dose of this magnitude (20 mg/kg) was tolerated and effective is a strong incentive to pursue similar in vivo studies with -defensins.
